HMGB3 and triple-negative breast carcinoma: Additionally, we discovered that HMGB3 expression levels were substantially greater in the basal-like subtype than in the nonbasal-like subtype (p<0.0001), and individuals with triple-negative breast cancer (TNBC) also showed the same pattern of change (p<0.0001) (Figures 3G, H).